CA-170 | m-entrepreneurship.com

Product Name :
CA-170

Search keywords :
DD1

drugId :
null

Target Vo:
V-domain Ig suppressor of T-cell activation

Target Vo Short Name :
VISTA

Moa_Name:
V-domain Ig suppressor of T-cell activation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aurigene

Active Company_Name :
Curis Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDIA2 Antibody
Phospho-Rb (Ser807) Antibody
Beta Actin Antibody HRP Conjugated: Beta Actin Antibody HRP Conjugated is a rabbit-derived HRP-conjugated antibody targeting beta-Actin with a molecular weight of approximately 42 KDa. Beta Actin Antibody HRP Conjugated can be used for WB experiments in human, mouse, rat, zebrafish, monkey, hamster, plant backgrounds.

Author: Betaine hydrochloride

Related Posts